“…Combined 18F-fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) is applied in several oncologic fields (3)(4)(5)(6)(7), especially in lymphoproliferative disorders (3); indeed, it is recommended both for staging after diagnosis and for end-of-treatment assessment of DLBCL (8). Whole Body Magnetic Resonance (WB-MR) with diffusion-weighted imaging (DWI) is a technique more and more applied in general, urgent (9)(10)(11)(12) and oncologic fields, especially in lymphoma and myeloma patients (13)(14)(15)(16)(17). Regarding the role of WB-MR in the evaluation of response to therapy there are promising preliminary results but larger studies are necessary to validate its reliability (18).…”